ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 095,12
0,33%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Heron Therapeautics Inc (HRTX)

  7. Heron Therapeautics Inc (HRTX) Actualités

HRTX Heron Therapeautics Inc

2,60
0,05 (1,96%)
04 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Heron Therapeautics Inc HRTX NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,05 1,96% 2,60 01:23:05
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
2,67 2,57 2,74 2,61 2,55
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
24/4/202414:00PRNUSHeron Therapeutics to Report First Quarter 2024 Financial..
11/4/202422:05PRNUSHeron Therapeutics to Host Investor Day on May 15, 2024 in..
28/3/202421:05PRNUSHeron Therapeutics Announces Presentation at the 23rd Annual..
13/3/202421:25APSBiotech Finds Mid-Week Success Following Q4 Earnings Release
12/3/202421:05PRNUSHeron Therapeutics Announces Fourth Quarter and Full-Year..
12/3/202412:22IHMARKETNEWSGlobal Markets Await U.S. Inflation Report: Mixed Movements..
28/2/202414:00PRNUSHeron Therapeutics to Report Fourth Quarter and Full Year..
14/2/202422:37EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202422:21EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
24/1/202415:25APSPremarket Heats Up For Biotech Before Opening Bell
24/1/202414:01EDGAR2Form 8-K - Current report
24/1/202402:00PRNUSHeron Therapeutics Announces FDA Approval of ZYNRELEF®..
20/1/202403:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/1/202403:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/1/202403:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/1/202403:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/1/202403:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/1/202403:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/1/202403:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/1/202403:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/1/202402:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/1/202423:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/1/202422:07EDGAR2Form 8-K - Current report
07/1/202423:00PRNUSHeron Therapeutics Announces Partnership with CrossLink Life..
22/12/202322:30EDGAR2Form 8-K - Current report
21/12/202323:25EDGAR2Form 8-K - Current report
06/12/202322:47EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
21/11/202318:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202316:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202318:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202318:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202318:25APSBiotech Shares Up Sharply Following Quarterly Results
14/11/202322:10EDGAR2Form 8-K - Current report
14/11/202322:05PRNUSHeron Therapeutics Announces Third Quarter 2023 Financial..
07/11/202322:05PRNUSHeron Therapeutics to Report Third Quarter 2023 Financial..
18/10/202301:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/8/202322:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/8/202322:08EDGAR2Form S-3 - Registration statement under Securities Act of..
14/8/202322:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202322:11EDGAR2Form 8-K - Current report
14/8/202322:05PRNUSHeron Therapeutics Announces Second Quarter 2023 Financial..
07/8/202322:05PRNUSHeron Therapeutics to Report Second Quarter 2023 Financial..
01/8/202319:56EDGAR2Form D - Notice of Exempt Offering of Securities
25/7/202322:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/7/202322:13EDGAR2Form SC 13D/A - General statement of acquisition of..
24/7/202315:12EDGAR2Form 8-K - Current report
24/7/202315:02PRNUSHeron Therapeutics Announces Cost Reduction Plan and..
24/7/202315:00PRNUSHeron Therapeutics Announces $30 Million Private Placement..
20/7/202300:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/7/202323:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Dernières Valeurs Consultées

NASDAQ
HRTX
Heron Therapeautics
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés